(Q46371267)

21 December 2017

review article

1 reference

title

Disturbances of calcium-PTH-vitamin D axis in chronic liver diseases (English)

1 reference

21 December 2017

main subject

vitamin D

0 references

chronic liver disease

0 references

author name string

Rodrigo O Moreira

series ordinal

1

1 reference

21 December 2017

Mônica P C Duarte

series ordinal

2

1 reference

21 December 2017

Maria Lucia F Farias

series ordinal

3

1 reference

21 December 2017

language of work or name

Portuguese

0 references

publication date

1 August 2004

1 reference

21 December 2017

Arquivos Brasileiros de Endocrinologia e Metabologia

published in

1 reference

21 December 2017

volume

48

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

page(s)

443-450

1 reference

21 December 2017

Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Osteodystrophy in patients with chronic hepatitis and liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Osteoporosis and skeletal fractures in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Ethanol reduces bone formation and may cause osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Evidence for secondary hyperparathyroidism in the osteomalacia associated with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Bone loss in primary biliary cirrhosis: absence of association with severity of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Osteoporosis in primary biliary cirrhosis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Vitamin D, parathyroid hormone, and bone mineral content of lumbar spine and femur in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Calcium absorption in bone disease associated with chronic cholestasis during childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Altered calcium homeostasis in adults with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Abnormal bone turnover in cystic fibrosis adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Bone mineral density and quantitative ultrasound in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Lack of evidence for ribavirin-induced bone loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Painful diffuse osteosclerosis after intravenous drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Absence of hyperparathyroidism in severe liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Effect of transplantation on bone: osteoporosis after liver and multivisceral transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

Doubling skeletal mass during adult life: The syndrome of diffuse osteosclerosis after intravenous drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302004000400004

10.1590/S0004-27302004000400004

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

release_3nd6p6exqzf3pjdfdgu4jnjeau

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3nd6p6exqzf3pjdfdgu4jnjeau

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

21 December 2017